Published :
Report ID:
Pages :
Format :
The Global Calcium Phosphate Bone Cement Market Size accounted for USD 797.6 Million in 2023 and is estimated to achieve a market size of USD 1,303.1 Million by 2032 growing at a CAGR of 5.7% from 2024 to 2032.
Calcium phosphate bone cement (CPC) is a biocompatible, moldable substance used in orthopedic and dentistry procedures to repair bone abnormalities. It resembles the mineral composition of real bone, encouraging bone regeneration and integration. CPC is often used to fill bone gaps, stabilize fractures, and support implants. It solidifies in place, providing structural support before eventually being resorbed and replaced by new bone tissue. Its biocompatibility and ability to conform to various shapes make it useful for minimally invasive operations.
Market |
Calcium Phosphate Bone Cement Market |
Calcium Phosphate Bone Cement Market Size 2023 |
USD 797.6 Million |
Calcium Phosphate Bone Cement Market Forecast 2032 |
USD 1,303.1 Million |
Calcium Phosphate Bone Cement Market CAGR During 2024 - 2032 |
5.7% |
Calcium Phosphate Bone Cement Market Analysis Period |
2020 - 2032 |
Calcium Phosphate Bone Cement Market Base Year |
2023 |
Calcium Phosphate Bone Cement Market Forecast Data |
2024 - 2032 |
Segments Covered |
By Type, By Application, By End-User, and By Geography |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Cardinal Health, Heraeus Medical, Stryker, Arthrex, TEKNIMED, DJO Global, Zimmer Biomet, Exactech, Trimph, DePuy Synthes, CryoLife, and Smith & Nephew. |
Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Patients and surgeons increasingly prefer minimally invasive procedures because of faster recovery times, less pain, and shorter hospital stays. Key manufacturers are also partnering to develop minimally invasive technologies in new markets. For example, in February 2023, Encision Inc. entered into a Proof of Concept Services Agreement with Vicarious Surgical Inc. The Vicarious surgical robot design aims to improve instrument precision, control, and visualization in robotically assisted minimally invasive surgery. In December 2022, Abbott also announced the launch of minimally invasive devices, TAVI, for heart valve therapy in India. These advancements by leading manufacturers are fuelling demand for calcium phosphate bone cement market.
Osteoporosis, fractures, and joint-related illnesses are becoming more common as the population ages and lifestyle factors change. For example, according to the National Institutes of Health (NIH), osteoporosis is the leading cause of fractures in postmenopausal women and older men. Osteoporosis is most prevalent among non-Hispanic white and Asian women. Non-Hispanic white men are more likely to develop osteoporosis. Some children and teenagers acquire an uncommon kind of idiopathic juvenile osteoporosis. The rise in bone-related health issues has increased the demand for effective bone repair materials such as calcium phosphate bone cement.
The creation of high-quality, bioactive calcium phosphate bone cement necessitates sophisticated manufacturing procedures and costly raw materials. This results in increased prices, which may limit its adoption, particularly in cost-sensitive countries.
The global growth in senior populations, who are more prone to bone density loss and fractures, is driving up demand for bone restoration options. According to the Asian Development Bank, the number of persons aged 60 and older in developing Asia and the Pacific would nearly treble by 2050, reaching 1.2 billion. Calcium phosphate bone cement's biocompatibility and bone regeneration capabilities make it a popular choice for addressing age-related concerns, which have created an opportunity for the burgeoning business.
The worldwide market for calcium phosphate bone cement is split based on type, application, end-user, and geography.
According to the calcium phosphate bone cement industry analysis, antibiotic-loaded bone cement dominates, particularly in infection-prone surgical operations that require localized antibiotic delivery. It is especially effective in revision operations and joint replacements since it reduces post-surgical infections, improving patient outcomes. Non-antibiotic-loaded bone cement is quickly expanding in the business due to its use in common orthopedic and dental operations, which eliminates the possibility of antibiotic resistance. Its low cost and suitability for individuals who are not concerned about infection make it a rapidly increasing part of the calsium phosphate bone cement market.
Orthopedic surgery is the leading application in the calcium phosphate bone cement market. Orthopedic surgery is also anticipated to show notable growth in market, because of the increasing prevalence of bone injuries and degenerative joint illnesses. Trauma and fracture repair and joint reconstruction are notabaly increasing the market revenue throughout the forecast period 2024 to 2032. Its capacity to offer structural support, facilitate bone healing, and adapt to diverse fracture geometries renders it indispensable in orthopedic operations. Its usage in spinal fusion for increased vertebral stability contributing to its leadership in this market. Dental applications such as bone grafting and dental implants are expanding as aesthetic dentistry and periodontal disease therapies become more prevalent. Similarly, the biocompatibility and simplicity of molding of calcium phosphate bone cement help with bone regeneration and structural integrity in craniofacial surgery, vertebroplasty, and kyphoplasty procedures.
According to the calcium phosphate bone cement market forecast, hospitals are the key end users, owing to the high amount of orthopedic procedures and trauma cases they handle. Their modern infrastructure and access to qualified medical professionals make them the ideal location for complex bone cement treatments. Ambulatory surgical centers (ASCs) and specialized clinics both contribute to market demand, albeit to a smaller amount than hospitals. Research and academic institutions are largely concerned with the development and study of novel applications, and so account for a lesser market share.
North America
Europe
Asia-Pacific
Latin America
The Middle East & Africa
North America leads the calcium phosphate bone cement market due to the presence of advanced healthcare infrastructure, high healthcare spending, and early adoption of cutting-edge medical technology. The presence of key market players, as well as intensive research and development activities, contribute to market growth. For example, Mayo Clinic orthopedic doctors are well-known both nationally and internationally for their surgical technical expertise and innovative treatments to both simple and difficult orthopedic problems. From diagnosis to treatment, Mayo Clinic orthopedic doctors on campuses in Minnesota, Arizona, and Florida are at the forefront of leveraging cutting-edge technology to drive market growth in North America.
The calcium phosphate bone cement market in Asia-Pacific is expanding rapidly due to rising healthcare investments, increased knowledge of advanced medical treatments, and a growing elderly population. According to Welcome to the United Nations (World Population Ageing 2023), population ageing is more advanced in Bangladesh and in its early stages in Rwanda and Angola. Furthermore, the increased prevalence of orthopedic injuries and dental difficulties, combined with medical tourism, is pushing demand for low-cost bone restoration options.
Some of the top calcium phosphate bone cement companies offered in our report Cardinal Health, Heraeus Medical, Stryker, Arthrex, TEKNIMED, DJO Global, Zimmer Biomet, Exactech, Trimph, DePuy Synthes, CryoLife, and Smith & Nephew.
The calcium phosphate bone cement market size was valued at USD 797.6 Million in 2023.
The CAGR of calcium phosphate bone cement is 5.7% during the analysis period of 2024 to 2032.
The key players operating in the global market are including Cardinal Health, Heraeus Medical, Stryker, Arthrex, TEKNIMED, DJO Global, Zimmer Biomet, Exactech, Trimph, DePuy Synthes, CryoLife, and Smith & Nephew.
North America held the dominating position in calcium phosphate bone cement industry during the analysis period of 2024 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of calcium phosphate bone cement during the analysis period of 2024 to 2032.
The current trends and dynamics in the calcium phosphate bone cement industry include growing demand for minimally invasive surgical procedures, increasing prevalence of orthopedic disorders and bone injuries, and advancements in biomaterial technology enhancing product performance.
The antibiotic-loaded bone cement type held the maximum share of the calcium phosphate bone cement industry.